Neurocrine Biosciences
Neurology and Endocrinology Research and Therapy | Neurocrine Biosciences.
Launch date
Employees
Market cap
$12.3b
Enterprise valuation
$11.5b (Public information from Sep 2024)
Share price
$117.75 NBIX
San Diego California (HQ)
Authorizing premium user...